The powerful regulation of bone mass exerted by the brain suggests the existence of bone-derived signals modulating this regulation or other functions of the brain. We show here that the osteoblast-derived hormone osteocalcin crosses the blood-brain barrier, binds to neurons of the brainstem, midbrain, and hippocampus, enhances the synthesis of monoamine neurotransmitters, inhibits GABA synthesis, prevents anxiety and depression, and favors learning and memory independently of its metabolic functions. In addition to these postnatal functions, maternal osteocalcin crosses the placenta during pregnancy and prevents neuronal apoptosis before embryos synthesize this hormone. As a result, the severity of the neuroanatomical defects and learning and memory deficits of Osteocalcin À/À mice is determined by the maternal genotype, and delivering osteocalcin to pregnant Osteocalcin À/À mothers rescues these abnormalities in their Osteocalcin À/À progeny. This study reveals that the skeleton via osteocalcin influences cognition and contributes to the maternal influence on fetal brain development.
INTRODUCTION
Bone was recently identified as an endocrine organ (Guntur and Rosen, 2012) . A hormone secreted by osteoblasts, osteocalcin, affects physiological processes as diverse as energy expenditure, glucose homeostasis, and male fertility (Ferron et al., 2010 ; Lee et al., 2007; Oury et al., 2011) . The latter function of osteocalcin led to the identification of its only known receptor, Gprc6a, which is expressed on Leydig cells (Oury et al., 2010; Pi and Quarles, 2012) . Given that most hormones act in many organs and regulate multiple physiological processes, it is likely that the spectrum of endocrine functions of osteocalcin is broader than what is already known.
In another development of skeletal biology, the brain was shown to determine bone mass accrual (Karsenty and Ferron, 2012) . This was revealed while studying the mechanisms whereby leptin inhibits bone mass accrual in mice, rats, sheep, and humans (Ducy et al., 2000; Elefteriou et al., 2004; Pogoda et al., 2006; Vaira et al., 2012) . A systematic, step-wise, and cell-specific genetic dissection in the mouse demonstrated that leptin does so by signaling in brainstem neurons to prevent the synthesis of serotonin, a neurotransmitter that decreases the activity of the sympathetic nervous system, which in turn inhibits bone mass accrual (Oury et al., 2010; Takeda et al., 2002; Yadav et al., 2009 ). The importance of this serotonin-dependent regulation of bone mass accrual is evidenced by the fact that serotonin reuptake inhibitors that increase intrasynaptic concentrations of serotonin in the brain can affect bone mass in humans (Gardier et al., 1996) .
Because it is so powerful (the absence of leptin signaling overrides the deleterious effect of the lack of sex steroid hormones on bone mass), this mode of regulation of bone mass raises the following questions: does bone signal back to the brain? If it does, what are the identities and functions of these bone-derived signals? These questions are also prompted by a clinical observation. Patients affected with Cleidocranial dysplasia (CCD), a disease caused by mutations in the osteoblast-specific transcription factor Runx2, often demonstrate cognitive impairment (McBrien et al., 2006; Nagamatsu et al., 2012; Soule, 1946) . Runx2 is the main regulator of Osteocalcin (Ocn) expression .
Clinical outcome studies and experimental evidence gathered in animal models both indicate that maternal health during pregnancy is a determinant of embryonic development (Challis, 2012; Hales and Barker, 1992; Lawlor et al., 2012) . Any direct maternal influence on vertebrate embryonic development should occur through the placenta, an organ allowing the transfer of circulating molecules from the mother to the embryo. However, maternally derived molecules that cross the placenta and affect brain development and functions in the progeny have not yet been identified. Because maternal health is a risk factor for neurologic and psychiatric diseases in the offspring, this is an important question to study (Van den Bergh et al., 2005; Weinstock, 2008) .
This study was initiated to determine whether the skeleton regulates any function of the brain. Testing this hypothesis revealed that osteocalcin crosses the blood-brain barrier (BBB), binds to neurons in the brainstem, midbrain, and hippocampus, and influences the synthesis of several neurotransmitters. Consequently, osteocalcin favors postnatally, and independently of its metabolic role, several behaviors by signaling in the brain. As importantly, during pregnancy maternal osteocalcin crosses the placenta and prevents neuronal apoptosis in the embryo before it can synthesize this hormone. This explains why this pool of osteocalcin determines the quality of spatial learning and memory in adult offspring. These results indicate that the skeleton via osteocalcin regulates cognition and is a mediator of the maternal influence on brain development and functions of the offspring (Broad and Keverne, 2011; Jansson and Powell, 2007) .
RESULTS

Osteocalcin Influences the Synthesis of Several Neurotransmitters
The passivity of the Ocn À/À mice, a feature reported by all investigators handling them since they were generated, was quantified by comparing their locomotion to that of wild-type (WT) littermates during light and dark phases or over 30 min of an open-field paradigm test . Both assays showed a significant decrease in locomotion in 3-month-old Ocn À/À mice. Given that this analysis was conducted in female mice, this decrease in locomotion could not be ascribed to a lack of sex steroid hormones as their synthesis is not regulated by osteocalcin in female mice (Oury et al., 2011) nor was it secondary to a measurable deficit in muscle functions ( Figure S1A available online). Locomotion was normal in mice lacking Gprc6a, the only known receptor for osteocalcin ( Figures 1A-1C) , implying that the passivity of Ocn À/À mice may not be a consequence of their metabolic abnormalities since these are equally severe in Ocn À/À and Gprc6a À/À mice (Figures S1B-S1E). This was further addressed by including Gprc6a À/À mice in subsequent experiments.
To determine whether this passivity was caused by perturbations in neurotransmitters that have accumulated in the brain, we measured neurotransmitter content in various areas of the brain of 3-month-old WT, Ocn À/À , and Gprc6a À/À mice. This analysis showed that GABA content was increased in all brain areas tested in Ocn À/À compared to WT mice ( Figure 1D ). In contrast, norepinephrine and serotonin contents were significantly decreased in the brainstem, whereas that of dopamine was decreased in the midbrain, cortex, and striatum of Ocn À/À mice ( Figures 1E-1G ). Glutamate levels were normal in the brains of Ocn À/À mice ( Figure S1I ). The contents of all these neurotransmitters were similar in WT and Gprc6a À/À brains ( Figures   S1F-S1H ).
An explanation for the changes in neurotransmitter accumulation in Ocn À/À mice is the alteration in expression of genes necessary for neurotransmitter biosynthesis. Expression of Gad1 and Gad2, two enzymes required for GABA biosynthesis, was increased in the brainstems of Ocn À/À mice ( Figure 1H ).
Expression of Tph2, the gene encoding the initial enzyme needed for brain serotonin synthesis (Walther et al., 2003) , and of Th that encodes the initial enzyme in dopamine and norepinephrine synthesis (Daubner et al., 2011; Palmiter, 2008) was decreased in the brainstem and midbrain, respectively (Figure 1H) . Conversely, in Esp À/À mice, which display an increase in the circulating levels of the undercarboxylated form of osteocalcin (Lee et al., 2007) , Tph2 expression in the brainstem was increased ( Figure S1J ). All these genes were normally expressed in Gprc6a À/À mice ( Figure 1H ), further suggesting that osteocalcin affects the synthesis of neurotransmitters in a Gprc6a-independent manner.
Osteocalcin Favors Several Behaviors
The increase in the content of GABA and the decrease of monoamine neurotransmitters (serotonin and catecholamine) in the brains of Ocn À/À mice should hamper their behavior. This was assessed in female WT, Ocn À/À , and Gprc6a À/À mice.
Anxiety-like behavior was analyzed by three conflict-based tests. The dark/light transition test exploits the innate aversion of rodents to brightly illuminated areas (Crawley, 1985; David et al., 2009) . The test apparatus consists of a dark, safe compartment and an illuminated, aversive one. Three parameters were recorded: (1) latency to enter the lit compartment, (2) time spent in the lit compartment, and (3) the number of transitions between compartments. Ocn À/À mice displayed longer latency and spent less time in the lit compartment, two indexes of anxiety-related behavior ( Figure 2A ). They also made fewer transitions between compartments, an index of anxiety-like behavior and of motorexploratory activity ( Figure 2A ). The next test, the elevated plus maze test (EPMT) (Holmes et al., 2000; Lira et al., 2003) mice showed a drastic decrease in the distance moved, time spent in the center, and vertical activity compared to WT littermates, all features indicative of greater anxiety-like behavior and decreased exploratory activity ( Figure 2C ). Anxiety is often accompanied by depression. This was first assessed by the tail suspension test (TST) in which animals are subjected to the inescapable stress of being suspended by their tails (Cryan et al., 2005; David et al., 2009) . In this test, an index of helplessness is the time spent immobile. This time was significantly increased in Ocn À/À mice ( Figure 2D ). In the forced swim test (FST), mice are forced to swim over 6 min in a glass cylinder filled with water from which they cannot escape. Over time, mice cease their attempts to escape and float passively, an indication of a depression-like behavior. 
Ocn
À/À mice spent 45% more time floating than WT mice ( Figure 2E ). Spatial learning and memory were assayed through the Morris water maze test (MWMT) that is thought to reflect functions of the hippocampus. This test relies on the ability of mice to use spatial cues to locate a submerged platform. Spatial learning is assessed through four trials a day for 10 to 12 days. Ocn À/À mice showed a nearly complete inability to learn over the course of 10 days ( Figure 2F ). Taken together, these tests showed that osteocalcin exerts a significant influence on anxiety, depression-like behaviors, learning, and memory. An electroretinogram did not detect any difference between Ocn À/À and WT mice, thus ruling out that these behavioral abnormalities were secondary to blindness ( Figure S2A ). Gprc6a À/À mice were indistinguishable from WT littermates for all these tests .
Osteocalcin Signals in Discrete Areas of the Brain Next we asked through a variety of approaches whether the molecular and behavioral abnormalities observed in Ocn À/À mice were indicative of a direct signaling of this hormone in the brain. We first tested whether osteocalcin crossed the BBB. For that purpose, we delivered subcutaneously vehicle or recombinant uncarboxylated, full-length, mouse osteocalcin (hereafter referred to as osteocalcin) in 3-month-old Ocn À/À mice. As a positive control, leptin, which crosses the BBB (Banks et al., 1996) , was delivered in the same conditions in 3-month-old ob/ob mice. Seven days later, leptin and osteocalcin contents were measured in the blood and various parts of the brain of ob/ob and Ocn À/À mice, respectively. As expected, leptin was detected in the brainstem and hypothalamus of ob/ob mice (Yadav et al., 2009 ) ( Figure S3A ), as for osteocalcin it accumulated in the brainstem, thalamus, and hypothalamus of Ocn À/À mice ( Figure 3A ). In the conditions of this assay, the quantity of osteocalcin that accumulated in each location in the brains of Ocn À/À mice was similar to that observed in the brains of WT mice ( Figures 3A and S3B ). When using carboxylated, full-length mouse osteocalcin (hereafter referred to as carboxylated osteocalcin), significantly less accumulated in the brainstem and hypothalamus and none in the midbrain ( Figure 3A ). To determine whether osteocalcin binds to neurons, we incubated sections of adult mouse brains with biotinylated uncarboxylated osteocalcin (300 ng/ml) or GST-biotin alone (1.5 mg/ ml) followed by immunofluorescence analysis with an anti-biotin antibody. In the midbrain, osteocalcin bound to neurons in the ventral tegmental area, a nucleus located close to the midline on the floor of the midbrain and enriched in dopaminergic neurons; in the brainstem, binding was detected in the dorsal and median raphe nuclei that contain serotonergic neurons, and in the hippocampus, osteocalcin bound to neurons of the CA3 region of the hippocampus ( Figure 3B ). In each location, this binding was specific as it was displaced by unlabeled osteocalcin ( Figure 3B ).
Second we asked whether, ex vivo, osteocalcin could signal in neurons to influence expression of genes needed for neurotransmitter synthesis. Brains were sliced at the level of the median and dorsal raphe of the brainstem so that they would be enriched in serotonin-producing neurons, or at the level of the substantia nigrae and ventral tegmental areas (VTAs) of the midbrain. Osteocalcin decreased Gad1 expression and increased Tph2 and Th expression in brainstem and midbrain explants, respectively, regardless of their genotypes ( Figure 3C ). Osteocalcin also decreased Gad1 expression by 65% and increased Tph2 expression 3-fold when added to primary hindbrain neuron (B) Binding of GST-biotin (1.5 mg/ml) (panel 1) and biotinylated uncarboxylated osteocalcin (300 ng/ml) (panels 2-4) to the dorsal (DR) (first row) and median (MR) (second row) raphe nuclei of the brainstem (identified by anti-5-HT immunofluorescence), to the ventral tegmental area (VTA) (third row) of the midbrain (identified by anti-TH immunofluorescence), and to the CA3 region (fourth row) of the hippocampus (identified anatomically). Panel 5: competition with unlabeled osteocalcin (1000-fold excess). Scale bars = 100 mm.
(C) Expression of Tph2 and Gad1 in brainstem and of Th in midbrain explants from WT and Gprc6a À/À mice, treated with 3 ng/ml osteocalcin or vehicle.
(D) Gene expression in mouse primary hindbrain neurons treated with osteocalcin (10 ng/ml) or vehicle.
(E) Calcium flux of hindbrain neurons responsive (n = 7) and unresponsive (n = 5) to osteocalcin (30 ng/ml).
(F and G) Extracellular current recordings of (F) neurons of the dorsal raphe nucleus and (G) GABAergic interneurons of the brainstem treated with osteocalcin (10 ng/ml). Error bars represent SEM. The statistical test on the top of each graph represents the Student's t test; p < 0.05 is significant.
cultures ( Figure 3D ). Osteocalcin influenced gene expression in a dose-dependent manner but with different optimal concentrations for each gene ( Figure S3C ). Two more assays confirmed that osteocalcin could signal in neurons of the brainstem. First, osteocalcin (30 ng/ml) induced calcium flux in hindbrain neurons collected at embryonic day 14.5 (E14.5) ( Figure 3E) ; second, whole-cell current clamp recording showed that osteocalcin could activate the action-potential frequency of neurons in the brainstem and the locus coeruleus ( Figures 3F and S3D ).
Osteocalcin also inhibited the action-potential frequency of the GABAergic interneurons of the brainstem, recognized by enhanced green fluorescent protein (eGFP) labeling using the glutamate decarboxylase (GAD)67-GFP knockin mouse model (Tanaka et al., 2006 ) ( Figure 3G ).
Lastly we asked whether osteocalcin acts in the brain in vivo to affect gene expression and behaviors. For that purpose, we delivered the hormone via intracerebroventricular (ICV) infusions (10 ng/hr) to Ocn À/À mice ( Figure S4A ). Measurements of osteocalcin in the blood of infused Ocn À/À mice showed that there was no leakage of the centrally delivered molecule into the general circulation ( Figure S4B ). This weeklong treatment normalized Tph2, Th, Gad1, and Gad2 expression and corrected fully anxiety and depression and partially the spatial learning and memory defects in Ocn À/À mice . Collectively, results of these ex and in vivo assays indicate that osteocalcin regulates neurotransmitter synthesis and behaviors in the mouse by directly acting in the brain. 
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Osteocalcin Signals in the Brain Postnatally
In the next experiment, we asked whether osteocalcin influences behaviors and neurotransmitter synthesis by acting postnatally.
To that end, we crossed mice harboring a floxed allele of Ocn with mice expressing Cre ERT2 under the control of the osteoblast-specific regulatory elements of the mouse a1Col1 gene (Ocn osb ERT2 ) . Ocn osb ERT2 mice showed a significant reduction (52%) of osteocalcin circulating levels following treatment with tamoxifen, thus verifying that we had efficiently, even if partially, inactivated this gene ( Figure S5 Figures 5A-5E ). Gad1 and Gad2 expression was increased in tamoxifen-treated Ocn osb ERT2 mice; this defect was partially corrected upon osteocalcin ICV infusion ( Figure 5F ). There was also a decrease in the content of serotonin and norepinephrine in the brainstem and of dopamine in the striatum of Ocn osb ERT2 mice ( Figure 5G ). Hence, osteocalcin acts postnatally to affect neurotransmitter synthesis and behaviors. Figure 5H ). Second, the near absence of the corpus callosum and the marked decrease in the area of the dentate gyrus noted in all Ocn À/À mice analyzed were never seen in tamoxifen-treated Ocn osb ERT2 mice (Figure 5I ). These observations suggested that osteocalcin influences fetal brain development.
Analysis of Ocn expression during development between E13.5 and E18.5 showed that this gene starts to be expressed in the developing skeleton at E16.5 and is not expressed anywhere in the brain at any of these developmental stages ( Figures  6A, S6A , and S6B). The same was true when analyzing OcnmCherry embryos ( Figure S6C) . And yet, osteocalcin was readily measured in the blood of E14.5 embryos, i.e., 2 days before expression of the gene becomes detectable ( Figure 6B ). Because Ocn is not expressed in the placenta (Figure 6A ), the only explanation for this observation is that maternal osteocalcin reaches the fetal blood stream. An ex vivo dual-perfusion system that monitors the transport of substances across the mouse placenta (Goeden and Bonnin, 2013) showed that osteocalcin could cross the placenta starting at E14.5 ( Figure 6C) . A larger transfer of maternal osteocalcin to the fetal circulation was observed at E15.5 and E18.5 ( Figure 6C ). In this assay, carboxylated osteocalcin failed to cross the placenta of pregnant mice at day 18.5 of gestation ( Figure S6D ).
In view of these results, we next used an ELISA to measure serum levels of the various forms of osteocalcin in embryos of various genotypes and origins (Ferron et al., 2010) (Figures  S6E and S6F) . That osteocalcin was detectable in the serum of E18.5 Ocn À/À embryos carried by Ocn +/À mothers established formally that maternal osteocalcin crosses the placenta in vivo ( Figures 6D and S6E ). Still at E18.5, osteocalcin circulating levels were 45% lower in WT embryos when their mothers were Ocn +/À than when their mothers were WT ( Figures 6D and S6E ). Likewise, osteocalcin circulating levels in E18.5 Ocn +/À embryos were 45% decreased when mothers were Ocn À/À compared to WT mothers ( Figures 6D and S6E ). In E16.5 embryos, osteocalcin circulating levels in WT embryos carried by WT mothers were 7.2 ng/ml but undetectable in embryos of any genotype carried by Ocn +/À mothers ( Figure 6D ). These results indicate that maternally derived osteocalcin contributes to the majority of the pool of this hormone present in the serum of embryos at E16.5 and E18.5. To determine the nature and extent of the influence of maternal osteocalcin on fetal brain development, we relied on histology and cell biology approaches. Regardless of the genotype of the mothers, there was no difference in the ratio of brain weight over body weight between WT and Ocn À/À embryos at E16.5
( Figure S6G ). By contrast, when compared to WT embryos carried by WT mothers, this ratio was markedly decreased in E18.5 Ocn À/À embryos if mothers were Ocn À/À mothers but not if they
were Ocn +/À ( Figure S6H ). Cresyl violet staining of histological sections showed an enlargement of the cerebral ventricles in the brains of E18.5 Ocn À/À embryos originating from Ocn À/À mothers compared to what was seen in WT embryos originating from WT mothers. This enlargement was not seen in either of these embryos when they originated from Ocn +/À mothers (Figure 6E) . The absence of osteocalcin in embryos also caused neuronal apoptosis of different severity depending on the genotypes of the mothers. Specifically, there was a 2-fold increase in the number of apoptotic cells in the hippocampus of E18.5 Ocn À/À embryos compared to WT embryos originating from WT mothers only if their mothers were Ocn À/À ( Figures 6F and   S6I ). Neuronal apoptosis was not seen throughout the brain and for instance was absent in the septal nuclei of Ocn À/À mice ( Figure S6J ). These results indicate that maternal osteocalcin affects fetal neurogenesis.
Maternal Osteocalcin Influences Spatial Learning and Memory and Neurogenesis in Adult Offspring
The influence of maternal osteocalcin on fetal neurogenesis led us to test whether this pool of the hormone also affects cognition and neurogenesis in the adult offspring. Given the massive apoptosis observed in the hippocampal region, we first asked, through the use of a three-shock contextual fear-conditioning paradigm (CFC), if the learning deficit revealed in Ocn À/À mice in the MWMT could be better linked to the hippocampus and if its severity was influenced by the genotype of the (B) Osteocalcin circulating levels in WT or Ocn À/À newborns (P0) and embryos (E13.5-E18.5).
(C) Ex vivo dual-perfusion system that monitors the transport of osteocalcin across the placenta. Uncarboxylated mouse osteocalcin (300 ng/ml) was injected through the uterine artery in placentas obtained from WT mice at E14.5, E15.5, and E18 Figure 6G ). Next, we used a modified version of the novel object recognition (NOR) paradigm (Ennaceur and Delacour, 1988; Denny et al., 2012) that assesses the rodent's ability to recognize a novel object in the environment. General activity (grid crossings) and object investigation (averaged across the two objects) were measured during two exposures. In the first one, mice were exposed to two objects, while in a second exposure, they faced a constant and a novel object and the parameter measured was the time spent for exploration of the novel object. A longer exploratory period betrays a hippocampal deficit in 129 sv/ev mice (Denny et al., 2012) . This is what was observed in Ocn À/À mice born from Ocn À/À mothers compared to Ocn À/À mice born from Ocn +/À mothers or WT mice ( Figure 6H ). Hence, both tests suggest a hippocampal origin to the spatial learning and memory defects seen in Ocn À/À mice.
To determine whether this deficit in spatial learning and memory was associated with an impairment of adult neurogenesis in the hippocampus, we performed BrdU staining and doublecortin (DCX) immunohistochemistry in the hippocampal regions of 3-month-old mice. There was a significant reduction in the number of DCX + and BrdU + neurons in Ocn À/À mice compared to WT mice regardless of the genotype of the mothers, although this reduction was more severe if mothers were Ocn À/À ( Figures   6I and 6J) . Hence, the maternal pool of osteocalcin is necessary for hippocampus-dependent learning in adult mice in part because it affects adult hippocampal neurogenesis. The functions of the maternal pool of osteocalcin described above implied that delivering the hormone to Ocn À/À females during their pregnancy could normalize hippocampal neurogenesis in Ocn À/À embryos and might improve behaviors in adult Ocn À/À offspring. This was tested following once-a-day injections of osteocalcin (240 ng/day) to pregnant Ocn À/À females mated with Ocn À/À males from E0.5 to E18.5. Neither mothers nor pups received the hormone after birth. This treatment had mild effect on parameters of anxiety or depression (except in the OFT) in 3-month-old Ocn À/À offspring but rescued almost entirely their deficit in learning and memory ( Figures 7A-7F ). To explain this striking rescue of spatial learning and memory, we conducted histological and biochemical analyses. The enlargement of the cerebral ventricles and the increase in neuronal apoptosis seen in the brains of E18.5 Ocn À/À embryos carried by Ocn À/À mothers were absent if these mothers had been injected with osteocalcin throughout their pregnancies ( Figures 7G and 7H) , and a Western blot analysis showed a decrease in caspase 3 cleaved levels in hippocampi of Ocn À/À embryos carried by osteocalcin-injected Ocn À/À mothers ( Figure S7 ). In 3-month-old offspring, cresyl violet staining and NeuN immunofluorescence showed a normalization of the area of the dentate gyrus in the hippocampi of Ocn À/À mice originating from osteocalcin-injected Ocn À/À mothers (Figure 7I) . Likewise, the contents of serotonin and norepinephrine were similar in 3-month-old WT and Ocn À/À mice born from osteocalcin-injected Ocn À/À mothers ( Figure 7J) ; the content of dopamine that was low in the striatum of Ocn À/À mice ( Figure 1F) was also normalized in Ocn À/À mice born from osteocalcininjected Ocn À/À mothers ( Figure 7J ). GABA levels remained elevated in the offspring of osteocalcin-injected Ocn À/À mice, albeit not significantly ( Figure 7K ). These experiments indicate that the maternal pool of osteocalcin is necessary for the acquisition of learning-and memory-like behaviors in the adult offspring in part because it prevents neuronal apoptosis in the hippocampus.
DISCUSSION
This study shows that the bone-derived hormone osteocalcin affects brain development and functions. After birth, osteocalcin favors neurotransmitter synthesis and postnatal neurogenesis, prevents anxiety-and depression-like behaviors, and enhances spatial learning and memory. During embryonic development, maternal osteocalcin crosses the placenta and prevents neuronal apoptosis in the hippocampus. This pool of the hormone is also required for optimal spatial learning and memory in the adult offspring. These results broaden the spectrum of functions of the skeleton, provide a molecular basis for the long-observed maternal influence on fetal brain development, and shed light on the cause of the decrease of cognitive functions with aging.
Signaling of Bone in the Brain
That a high serotonin content in the brain results in a high bone mass despite a hypogonadism (Ducy et al., 2000; Yadav et al., 2009) (legend continued on next page) any obvious muscular or metabolic causes. This investigation showed that osteocalcin favors expression of genes necessary for the synthesis of monoamine neurotransmitters and inhibits the ones needed for GABA synthesis. As a result, the contents of serotonin, dopamine, and norepinephrine are low, whereas that of GABA is high in the brains of Ocn À/À mice. Of note, the decrease in norepinephrine content observed in the brains of Ocn À/À mice may explain the high bone phenotype originally noted in the Ocn À/À mice (Ducy et al., 1996) .
Several observations indicate that osteocalcin signals in the brain. The first one is that this hormone, when uncarboxylated, crosses the BBB and binds specifically to neurons of the brainstem, midbrain, and hippocampus. The second one is that osteocalcin favors the expression of genes necessary for serotonin and catecholamine synthesis and inhibits the expression of genes involved in GABA biosynthesis by acting directly on neurons. Likewise, treatment of hindbrain neurons with osteocalcin affects calcium flux and the action-potential-firing rate of various neurons and interneurons of the brainstem.
Postnatal Functions of Osteocalcin in the Brain
A major consequence of the osteocalcin regulation of neurotransmitter synthesis is that this hormone influences behaviors. For instance, osteocalcin prevents anxiety and depression. The complete rescue of the anxiety and depression phenotypes seen in Ocn À/À mice upon ICV infusions of the hormone together with the deleterious effect of a postnatal Ocn inactivation on anxiety and depression were two further pieces of evidence that osteocalcin acts in the brain and postnatally to affect behaviors. Osteocalcin also favors spatial learning and memory as determined by several tests reflecting functions of the hippocampus (Morris et al., 1982) . This is consistent with the facts that the dentate gyrus area is smaller and that neuronal survival and adult neurogenesis in the hippocampus are decreased in Ocn À/À mice.
We note that skeletal dysplasia characterized by a decrease in bone formation can be associated with cognitive impairment (McBrien et al., 2006; Nagamatsu et al., 2012; Soule, 1946) . This is, for instance, the case with CCD, a disease caused by a loss-of-function mutation in Runx2, which is an osteoblastspecific transcription factor and a major regulator of Ocn expression Lee et al., 1997; Mundlos et al., 1997) . It is thus possible that, as is the case for its other functions (Oury et al., 2013) , the neuromodulatory functions of osteocalcin described in this study may be conserved in humans.
Bone, Osteocalcin, and Organismal Aging During aging, there is often a decrease in bone mass and a mild to severe cognitive impairment that in turn favors falls and bone fractures , Hence, a vicious circle develops between bone mass and cognition during aging. In that regard, our results may be important in two respects. First, they raise the prospect that a decrease in bone mass as seen during aging may be a cause of the decrease in cognitive functions seen in the older population because of a decrease in the synthesis and/or activation of osteocalcin. Therefore, they suggest that improving bone health during aging may have beneficial effects on cognition. The availability of multiple mouse models with either decreased bone formation or increased bone resorption will now allow testing of whether modulating osteocalcin synthesis by osteoblasts or its activation by bone resorption will affect behaviors. In broader terms, the fact that osteocalcin favors functions such glucose homeostasis, male fertility, and cognitive functions that deteriorate with age raises the testable hypothesis that bone, through its endocrine function, may be a determinant of organismal aging.
Functions of Maternal Osteocalcin
Ocn is one of the latest genes to be expressed during skeletogenesis, therefore it was expected that this hormone would not exert any significant functions during development. Our study shows, however, that the maternal pool of this hormone is needed for fetal brain development.
Indeed, osteocalcin is detected in the blood of embryos 2 days before they begin to express Ocn, and measurements of circulating levels of this hormone in WT or Ocn À/À embryos carried by either WT or Ocn +/À mothers showed that the majority of osteocalcin present in the circulation of embryos originates from the mother. Histological analysis of the brains of Ocn À/À embryos carried by either Ocn À/À or Ocn +/À mothers showed that maternal osteocalcin is needed to prevent neuronal apoptosis, at least in the hippocampus. The undercarboxylated form of osteocalcin, the form that increases insulin and testosterone biosynthesis (Ferron et al., 2010; Oury et al., 2013) , is also the only one crossing the placenta efficiently. This, along with the fact that it is also the form of the hormone that crosses the BBB more efficiently, suggests that it may be the active form of osteocalcin in the brain (Lee et al., 2007; Ferron et al., 2010) . By affecting fetal brain development, maternal osteocalcin also favored behavior in the adult offspring, as providing this hormone to Ocn À/À mothers during their pregnancies rescued almost completely the spatial learning and memory deficits in their adult Ocn À/À progeny. It also improved, albeit modestly, some parameters of anxiety in these progenies. In view of these results, it is tempting to speculate that a mediocre bone health in the mother, leading to a decrease in osteocalcin synthesis, may contribute to the high incidence of neuropsychiatric diseases in the children of women undernourished during pregnancy, as undernutrition hampers bone remodeling (Seibel, 2002) . This hypothesis that has important biomedical implications can be tested with various animal models.
(J and K) HPLC measurements of serotonin (J) and norepinephrine (NE) (J) content in the brainstem, dopamine content in the striatum (J), and GABA content in the brainstem, midbrain, and striatum (K) of WT and Ocn À/À embryos originating from osteocalcin-injected Ocn À/À mothers.
Error bars represent SEM. The statistical test on the top of each graph represents the Student's t test; p < 0.05 is significant. For (F), (a) means p value of < 0.05 versus WT and (b) means p value of < 0.05 versus Ocn À/À originating from Ocn À/À mothers; p < 0.05 is significant.
Mediation of Osteocalcin Functions in the Brain
The existence of substantial metabolic abnormalities in Ocn À/À mice was a a potential confounding factor for the interpretation of the results. Although we cannot formally rule out that these metabolic abnormalities may contribute to the behavioral phenotypes of the Ocn À/À mice, we note that mice lacking Gprc6a, the only known receptor for osteocalcin, are indistinguishable from Ocn À/À mice in terms of energy metabolism and do not present any of the molecular and behavioral defects seen in the absence of Ocn. The behavioral difference existing between Ocn À/À and Gprc6a À/À mice suggests that, like other hormones and neuromodulators, osteocalcin uses several receptors to fulfill all its known functions. Hence, our findings raise the question of the molecular mechanisms used by this hormone in the brain. Addressing this question on both molecular and genetic grounds is now a priority if we want to understand the entire spectrum of functions of osteocalcin in the brain.
EXPERIMENTAL PROCEDURES
Mice and Treatment Ocn
, and Ocn flox/flox mice have been described (Ducy et al., 1996; Oury et al., 2011) . All experimental measurements and behavioral studies were conducted with female mice only. All mice were maintained on a pure 129 sv/ev genetic background except the inducible deletion Ocn model (Ocn osb ERT2 ) (mixed background: 25% C57/BL6 and 75% 129 sv). For inducible gene deletion, tamoxifen was injected daily intraperitoneally (IP) (1 mg/ 20 g of body weight) for 7 days. Controls for the inducible inactivation of Ocn were a1Col1-Cre, Ocn flox/flox , and WT mice. Each group described is represented individually in each panel. For osteocalcin delivery to pregnant mice, IP injections (240 ng/day) were performed once a day from E0.5 to E18.5. For osteocalcin or leptin delivery in Ocn À/À or ob/ob mice, pumps (Alzet micro-osmotic pump, Model 1002) delivering osteocalcin (300 ng/hr), leptin (50 ng/hr), or vehicle were surgically installed subcutaneously in the back of 3-month-old mice. For rescues of behaviors in Ocn À/À mice, osteocalcin (10 ng/hr) or vehicle was delivered ICV. Unless specified otherwise, statistical analyses were performed using two-tailed Student's t test. Error bars denote mean ± standard error of the mean (SEM0. A p value of < 0.05 was considered statistically significant.
Hormonal Measurement
Osteocalcin and leptin contents in serum (ng/ml) and tissues (ng/mg) were measured with specific ELISAs (mouse osteocalcin EIA kit Millipore] ). Circulating levels of the carboxylated, undercarboxylated, or uncarboxylated forms of osteocalcin were measured by ELISA (Ferron et al., 2010) .
Real-Time RNA Transcript Determination RNA was isolated from primary neurons or tissue using TRIZOL (Invitrogen). cDNA synthesis was performed following standard, and qPCR analyses were done using specific qPCR primers from (http://www.sabiosciences. com/RT2PCR.php) SABiosciences and expressed relative to Gapdh levels.
High-Performance Liquid Chromatography
Serotonin, catecholamine, and GABA contents were measured by high-performance liquid chromatography (HPLC) (Bach et al., 2011) . Neurotransmitter contents in 7 to 15 mice of each genotype were measured in cerebral cortex, striatum, hippocampus, hypothalamus, midbrain, brainstem, and cerebellum. 
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